Pifeltro

Active Ingredient(s): Doravirine
FDA Approved: * August 30, 2018
Pharm Company: * MSD MERCK CO
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Pifeltro Overview

Doravirine, sold under the brand name Pifeltro, is a non-nucleoside reverse transcriptase inhibitor medication developed by Merck & Co. for use in the treatment of HIV/AIDS. Doravirine was approved for medical use in the United States in August 2018.[2] References ^ Collins, Simon; Horn, Tim. "The Antiretroviral Pipeline" (PDF). Pipeline Report. p.10. Archived from the original (PDF) on 11 March 2016. Retrieved 6 December 2015. ^ "Drug Approval Package: Pifeltro (dor...

Read more Pifeltro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doravirine

Recent Pifeltro Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doravirine
  • Tablet: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Pifeltro: (1 result)

Sorted by National Drug Code
  • 0006-3069 Pifeltro 100 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Other drugs which contain Doravirine or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA